Table 5 National Institutes of Health Stroke Scale (NIHSS) among patients group
From: Paradoxical role of hepatocyte growth factor in ischemic stroke: stroke risk/stroke recovery
The patient group (100 stroke patients) | Test | P value | |||
|---|---|---|---|---|---|
Carotid atherosclerosis N = 50 | Cardioembolic N = 50 | Total N = 100 | |||
NIHSS | |||||
X ± SD | 12.64 ± 9.89 | 13.88 ± 8.61 | 13.26 ± 9.24 | 0.69 | 0.49 |
Range | 1–40 | 1–35 | 1–40 | ||
No | % | No | % | X2 | ||||
|---|---|---|---|---|---|---|---|---|
NIHSS | ||||||||
Minor impairment | 15 | 30 | 11 | 22 | 26 | 26 | 2.10 | 0.55 |
Moderate | 13 | 26 | 13 | 26 | 26 | 26 | ||
Moderate-to-severe | 11 | 22 | 17 | 34 | 28 | 28 | ||
Severe impairment | 11 | 22 | 9 | 18 | 20 | 20 | ||